Journal
INTERNAL MEDICINE
Volume 48, Issue 7, Pages 569-572Publisher
JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.48.1794
Keywords
pegylated interferon alpha; hepatitis C infection; polyradiculoneuropathy; anti-ganglioside antibody
Categories
Ask authors/readers for more resources
Polyethylene glycol-interferon alpha (PEG-IFN alpha) has been used as the standard treatment for hepatitis C virus (HCV) infection. There have been no previous reports of polyradiculoneuropathy with anti-ganglioside antibodies induced by PEG-IFN alpha-2b. We report a 59-year-old man who developed polyradiculoneuropathy during treatment with PEG-IFN alpha-2b for chronic HCV infection. Serum levels of anti-asialo-GM1 (GA1) and anti-GM1 antibodies were elevated. Cessation of therapy with double filtration plasmapheresis resulted in marked improvement in his symptoms accompanied by a reduction in the antibody level. PEG-IFN alpha-2b may induce peripheral neuropathy mediated by anti-GA1 and anti-GM1 antibodies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available